| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
|
Nat Genet
|
2004
|
2.44
|
|
2
|
Patterns of pulmonary complications associated with sirolimus.
|
Respiration
|
2005
|
2.20
|
|
3
|
Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies.
|
Am J Surg Pathol
|
2010
|
2.16
|
|
4
|
Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
|
J Clin Oncol
|
2004
|
2.04
|
|
5
|
Stat3 promotes metastatic progression of prostate cancer.
|
Am J Pathol
|
2008
|
1.85
|
|
6
|
Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
|
Clin Cancer Res
|
2003
|
1.83
|
|
7
|
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
|
Lung Cancer
|
2011
|
1.62
|
|
8
|
A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens.
|
Cancer
|
2002
|
1.60
|
|
9
|
Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.
|
Cancer Res
|
2002
|
1.58
|
|
10
|
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
|
Endocr Relat Cancer
|
2013
|
1.57
|
|
11
|
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
|
Lancet Oncol
|
2012
|
1.54
|
|
12
|
Advancing a clinically relevant perspective of the clonal nature of cancer.
|
Proc Natl Acad Sci U S A
|
2011
|
1.47
|
|
13
|
HER2 gene status in primary breast cancers and matched distant metastases.
|
Breast Cancer Res
|
2007
|
1.45
|
|
14
|
Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols.
|
Urology
|
2013
|
1.39
|
|
15
|
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.
|
Virchows Arch
|
2012
|
1.34
|
|
16
|
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.
|
Mod Pathol
|
2010
|
1.33
|
|
17
|
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.
|
Prostate
|
2003
|
1.26
|
|
18
|
Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.
|
Clin Cancer Res
|
2005
|
1.26
|
|
19
|
Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
|
PLoS One
|
2012
|
1.26
|
|
20
|
Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
|
Mol Endocrinol
|
2002
|
1.22
|
|
21
|
ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.
|
Mol Endocrinol
|
2011
|
1.21
|
|
22
|
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
|
Cancer Res
|
2008
|
1.21
|
|
23
|
Expression patterns of potential therapeutic targets in prostate cancer.
|
Int J Cancer
|
2005
|
1.20
|
|
24
|
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
|
Endocrinology
|
2007
|
1.19
|
|
25
|
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.
|
Endocr Relat Cancer
|
2010
|
1.16
|
|
26
|
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer.
|
Int J Cancer
|
2006
|
1.15
|
|
27
|
Expression of voltage-gated potassium channels in human and mouse colonic carcinoma.
|
Clin Cancer Res
|
2007
|
1.15
|
|
28
|
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.
|
Am J Pathol
|
2010
|
1.11
|
|
29
|
ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
|
J Cell Physiol
|
2006
|
1.11
|
|
30
|
Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone.
|
J Thorac Oncol
|
2013
|
1.09
|
|
31
|
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
|
Int J Cancer
|
2007
|
1.08
|
|
32
|
Expression of Bcl-2 family member Bid in normal and malignant tissues.
|
Neoplasia
|
2002
|
1.07
|
|
33
|
Expression of NKX3.1 in normal and malignant tissues.
|
Prostate
|
2003
|
1.07
|
|
34
|
Deep clonal profiling of formalin fixed paraffin embedded clinical samples.
|
PLoS One
|
2012
|
1.03
|
|
35
|
Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
|
Am J Respir Crit Care Med
|
2009
|
1.02
|
|
36
|
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
|
Int J Cancer
|
2009
|
1.00
|
|
37
|
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy.
|
Int J Cancer
|
2009
|
1.00
|
|
38
|
Characterization and clinical relevance of ALDHbright populations in prostate cancer.
|
Clin Cancer Res
|
2013
|
0.99
|
|
39
|
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
|
J Thorac Oncol
|
2014
|
0.98
|
|
40
|
Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients.
|
Clin Cancer Res
|
2004
|
0.97
|
|
41
|
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.
|
Hum Pathol
|
2011
|
0.94
|
|
42
|
Role of KCNMA1 in breast cancer.
|
PLoS One
|
2012
|
0.94
|
|
43
|
ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
|
Int J Cancer
|
2007
|
0.94
|
|
44
|
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
|
Eur J Cancer
|
2012
|
0.94
|
|
45
|
Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.
|
J Transl Med
|
2011
|
0.94
|
|
46
|
Urine cytology findings of polyomavirus infections.
|
Adv Exp Med Biol
|
2006
|
0.93
|
|
47
|
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.
|
Lung Cancer
|
2012
|
0.92
|
|
48
|
Risk factors for polyoma virus nephropathy.
|
Nephrol Dial Transplant
|
2008
|
0.91
|
|
49
|
An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system.
|
Am J Clin Pathol
|
2006
|
0.90
|
|
50
|
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
|
Lung Cancer
|
2012
|
0.89
|
|
51
|
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters.
|
J Thorac Oncol
|
2014
|
0.89
|
|
52
|
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives.
|
Expert Rev Anticancer Ther
|
2013
|
0.89
|
|
53
|
Physical and transcript map of the hereditary prostate cancer region at xq27.
|
Genomics
|
2002
|
0.88
|
|
54
|
Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation.
|
Mod Pathol
|
2007
|
0.87
|
|
55
|
Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
|
Prostate
|
2015
|
0.87
|
|
56
|
Abundant expression of AMACR in many distinct tumour types.
|
Pathology
|
2006
|
0.86
|
|
57
|
Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature.
|
Arch Pathol Lab Med
|
2004
|
0.86
|
|
58
|
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
|
Eur J Cancer
|
2008
|
0.86
|
|
59
|
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
|
J Pathol
|
2011
|
0.86
|
|
60
|
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.
|
J Clin Pathol
|
2006
|
0.86
|
|
61
|
Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens.
|
Lung Cancer
|
2009
|
0.85
|
|
62
|
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.
|
Mol Endocrinol
|
2008
|
0.85
|
|
63
|
Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer.
|
Hum Pathol
|
2013
|
0.85
|
|
64
|
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
|
Prostate
|
2012
|
0.85
|
|
65
|
STAT5A/B gene locus undergoes amplification during human prostate cancer progression.
|
Am J Pathol
|
2013
|
0.84
|
|
66
|
Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm.
|
Chest
|
2005
|
0.84
|
|
67
|
PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
|
Am J Pathol
|
2012
|
0.84
|
|
68
|
Role of fluorescence in situ hybridization in lung cancer cytology.
|
Acta Cytol
|
2012
|
0.84
|
|
69
|
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).
|
Clin Cancer Res
|
2012
|
0.83
|
|
70
|
Lung resection in hematologic patients with pulmonary invasive fungal disease.
|
Chest
|
2012
|
0.83
|
|
71
|
Application of personalized medicine to solid tumors: opportunities and challenges.
|
Swiss Med Wkly
|
2012
|
0.83
|
|
72
|
DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
|
Cancer
|
2002
|
0.83
|
|
73
|
Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues.
|
Pathology
|
2006
|
0.82
|
|
74
|
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.
|
PLoS One
|
2013
|
0.82
|
|
75
|
Progressive pulmonary sarcoidosis--a fibroproliferative process potentially triggered by EGR-1 and IL-6.
|
Sarcoidosis Vasc Diffuse Lung Dis
|
2006
|
0.82
|
|
76
|
Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology.
|
Chest
|
2006
|
0.82
|
|
77
|
Treatment and detection of ALK-rearranged NSCLC.
|
Lung Cancer
|
2013
|
0.82
|
|
78
|
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.
|
J Virol
|
2012
|
0.82
|
|
79
|
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
|
Int J Cancer
|
2013
|
0.82
|
|
80
|
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
|
Chest
|
2010
|
0.82
|
|
81
|
Montelukast and Churg-Strauss syndrome.
|
Swiss Med Wkly
|
2004
|
0.81
|
|
82
|
Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization.
|
J Biomed Opt
|
2002
|
0.81
|
|
83
|
Clonal evolution and therapeutic resistance in solid tumors.
|
Front Pharmacol
|
2013
|
0.81
|
|
84
|
HPV L1 detection discriminates cervical precancer from transient HPV infection: a prospective international multicenter study.
|
Mod Pathol
|
2013
|
0.81
|
|
85
|
Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis.
|
Respir Med
|
2007
|
0.79
|
|
86
|
ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer.
|
Virchows Arch
|
2012
|
0.78
|
|
87
|
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
0.78
|
|
88
|
Tissue microarrays meet cytopathology.
|
Acta Cytol
|
2006
|
0.77
|
|
89
|
Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology.
|
Cancer Cytopathol
|
2011
|
0.77
|
|
90
|
Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
|
Cancer Cytopathol
|
2013
|
0.77
|
|
91
|
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?
|
Hum Pathol
|
2011
|
0.76
|
|
92
|
Genomic analysis and selected molecular pathways in rare cancers.
|
Phys Biol
|
2012
|
0.76
|
|
93
|
Editorial comment on: the value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.
|
Eur Urol
|
2007
|
0.75
|
|
94
|
Anaplastic lymphoma kinase 1 detected by immunohistochemistry in non-small cell lung cancer: a promising feature?
|
Hum Pathol
|
2010
|
0.75
|
|
95
|
Dysplastic cells in cytological cervical samples show a high incidence of chromosomal abnormalities.
|
Diagn Cytopathol
|
2010
|
0.75
|
|
96
|
[Urinary cytology and molecular markers].
|
Ann Pathol
|
2010
|
0.75
|
|
97
|
[Atypical urothelial cells in the urine].
|
Ann Pathol
|
2010
|
0.75
|
|
98
|
An unexpected cause of diffuse alveolar hemorrhage in a kidney transplant patient.
|
Respiration
|
2014
|
0.75
|
|
99
|
Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens.
|
Virchows Arch
|
2014
|
0.75
|
|
100
|
Report on Norrie's cytology.
|
Acta Ophthalmol
|
2010
|
0.75
|
|
101
|
An online quiz uncovers limitations of morphology in equivocal lung cytology.
|
Cancer
|
2006
|
0.75
|
|
102
|
Making cytological diagnoses on digital images using the iPath network.
|
Acta Cytol
|
2014
|
0.75
|
|
103
|
There is more than meet the eyes in head and neck cytopathology.
|
Diagn Cytopathol
|
2014
|
0.75
|
|
104
|
Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology.
|
Cancer Cytopathol
|
2014
|
0.75
|
|
105
|
Contralateral recurrence of a malignant solitary fibrous tumor of the pleura.
|
Interact Cardiovasc Thorac Surg
|
2010
|
0.75
|
|
106
|
Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy.
|
Virchows Arch
|
2014
|
0.75
|
|
107
|
Common Fluorescence In Situ Hybridization Applications in Cytology.
|
Arch Pathol Lab Med
|
2016
|
0.75
|